Matches in Nanopublications for { ?s ?p "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP433540.RADxtkbUUQSj8RFJoLWltQlNX34rWgDbd6B1TPnzmnvSw130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433540.RADxtkbUUQSj8RFJoLWltQlNX34rWgDbd6B1TPnzmnvSw130_provenance.
- assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP241010.RAnN5kLQmImB7OBPgMVt3PymJQTaTrEiozsRtxICIJCBA130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241010.RAnN5kLQmImB7OBPgMVt3PymJQTaTrEiozsRtxICIJCBA130_provenance.
- NP926085.RAX8W6cMY_pwKafC6br2DrVRX8fxYx_U-FD0ZkHbThnmg130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926085.RAX8W6cMY_pwKafC6br2DrVRX8fxYx_U-FD0ZkHbThnmg130_provenance.
- NP926089.RAXzaF3FjZJNbcjHnd4-Me32lPku8cmzcloUxXjzJn-U8130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926089.RAXzaF3FjZJNbcjHnd4-Me32lPku8cmzcloUxXjzJn-U8130_provenance.
- NP926091.RAanpvgDo-R9sV_JBy1K7mOiFA-rp2WmiK0kD41-_0eYM130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926091.RAanpvgDo-R9sV_JBy1K7mOiFA-rp2WmiK0kD41-_0eYM130_provenance.
- NP648471.RACA8Rp0_QbgM4P2iYV4xl2sgyLdU7eUwlJQEHpZTTfAI130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648471.RACA8Rp0_QbgM4P2iYV4xl2sgyLdU7eUwlJQEHpZTTfAI130_provenance.
- NP241077.RAzRAUEYEwd4NjrXt1fg_SCcL_poroLue-kt_p8wTK_J8130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241077.RAzRAUEYEwd4NjrXt1fg_SCcL_poroLue-kt_p8wTK_J8130_provenance.
- NP439673.RA769hcTzxAVPrjviQ03QEsrDoJxLI5h3lexnZQClvar8130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439673.RA769hcTzxAVPrjviQ03QEsrDoJxLI5h3lexnZQClvar8130_provenance.
- NP439729.RAFqvLnjtOW-aFCUUwV-LVhLku0DHfbUIuLJo5qp98_3A130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439729.RAFqvLnjtOW-aFCUUwV-LVhLku0DHfbUIuLJo5qp98_3A130_provenance.
- NP648405.RAPqLp9sop5BWTisZn1nWdneEtIADr7rhqEKH53IN-z8w130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648405.RAPqLp9sop5BWTisZn1nWdneEtIADr7rhqEKH53IN-z8w130_provenance.
- NP926086.RA5Pq_3JhJe7aoaRck66lzGbpDbgXKAGNmvyPqwhgW-5I130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926086.RA5Pq_3JhJe7aoaRck66lzGbpDbgXKAGNmvyPqwhgW-5I130_provenance.
- NP926088.RA4_47Efi1Q76pNcONnfPyn0exo8VgcrQ0VGGeMSNXcTg130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926088.RA4_47Efi1Q76pNcONnfPyn0exo8VgcrQ0VGGeMSNXcTg130_provenance.
- NP926090.RA4edUOVL89AJOh6GFknQPfcfnu65NV0lXvR9UXdTDUNs130_assertion description "[The assay is designed to detect epigenetic modifications in the 3 markers GSTP1, RAR?2 and APC, which are indicative of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926090.RA4edUOVL89AJOh6GFknQPfcfnu65NV0lXvR9UXdTDUNs130_provenance.